The protein analysis market has significant potential bolstered by the rising demand from drug discovery and personalized medicine. The capabilities and possibilities of protein analysis market growth increase with growing new technologies and technological advancement in the market. Emerging economies such as China, Japan and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the protein analysis market. This market is expected to obtain investments and funding from government and private ventures, research institutes and universities to explore its potential. Growing clinical trials, drug discovery and clinical diagnostic and research through the protein analysis market will further boost this market in the near future. Sedentary lifestyles, unhealthy eating habits and upsurge in infectious viral and bacterial diseases are also creating opportunities for the protein analysis market. The global rise in infectious and noninfectious diseases, growing population, technological advancements and innovation are some other factors creating considerable demand within the protein analysis market.
The scope of this study covers the current market for drug discovery, clinical diagnostic and research into personalized medicine and so forth. The report also includes regulatory aspects, current and developing technologies, market projections and market share. Patents, clinical trials, innovations and opportunities, as well as the latest trends are also analyzed and discussed. The report intends to explain the key trends of protein analysis technologies. It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.
The Report Includes:
- 56 data tables and 37 additional tables
- An overview of the global market for protein analysis and oncoproteomics within the biotechnology industry
- Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of the current market for drug discovery, clinical diagnostic and research into personalized medicine and so forth
- Discussion of factors such as global rise in infectious and noninfectious diseases, growing population, technological advancements and innovation, which create considerable demand within the protein analysis market
- Relevant patents analysis, clinical trials, innovations and opportunities
- Evaluation of key trends, present and future market strategies, technological advancements, and regulatory updates that have a major say in the protein analysis market
- Company profiles of the leading industry players, including Bio-Rad Laboratories Inc., Danaher Corp., GE Healthcare, GlaxoSmithKline PLC, GD Biosciences and Pfizer
Membership Price:
Contact us for membership pricing.
Table of Contents
Executive Summary
Protein analysis is a term used for analysis of the entire protein complement of a cell or an organism under a given set of conditions. It has been used widely in various applications such as drug discovery and clinical diagnostics. Rising demand and U.S. Food and Drug Administration (FDA) approvals of personalized medicines due to their numerous benefits have been two of the major factors driving the
market growth. As protein analysis is widely used for personalized medicines, it enables the market to grow significantly. Additionally, a rising aging population and an increase in lifestyle diseases have been motivating the market. According to theWorld Health Organization, cardiovascular diseases (CVDs) have been estimated as one of the major causes of mortality, and they account for more than 17.3 million deaths per year. It is further estimated that the fatalities due to CVDs are expected to reach 23.6 million by 2030.
These lifestyle diseases are growing at a significant rate, and protein analysis can be act as a bridge for drug discovery, customized medicines, biomarkers and research programs. Further, the diabetic population was recorded as 415 million in 2015, and it is projected that this will reach 642 million by 2040. This prevalence of lifestyle-related disorders reflects the need for protein analysis as a bridge for the drug discovery, customized medicines, and biomarkers, thus promoting the market. Healthcare research and development (R&D) spending plays a significant role in the growth of the protein analysis market. As transformative research is responsible for the development of new biomarkers and next-generation diagnostics and therapeutics, healthcare expenditure is a crucial element for the market.
Globally, national governments have been revising their healthcare expenditure taking into account increasing R&D. As a result, the overall increase in the healthcare expenditure globally would drive the market, as research institutes will be able to obtain increased funding by governments for drug discovery. Strict regulatory approvals of protein analysis instruments have been one of the major restraints of the protein analysis market. These products require regulatory approval by the FDA and other regulatory bodies as they govern a broad range of activities such as quality management, design and development, labeling, manufacturing and so forth. Additionally, there are various regulations for manufacturers and their customers, along with regulations in the areas of health and safety, packaging, product content and trade restrictions.
Manufacturers are required to follow complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws, violations of which can result in penalties and restrictions on the conduct of business. Additionally, the high costs of these instruments affect their adoption in the industry. Both of these factors have a negative effect on the growth of protein analysis market. However, technological advancements in mass spectrometry/liquid chromatography (MS/LC) instrumentation, protein separation and emerging markets in developing economies such as China, Japan, and South Korea are expected to drive the market growth in the upcoming years.
Companies Mentioned
- Abcodia
- Advance Proteome Therapeutics Corp.
- Agilent Technologies Inc.
- Anatrace
- Applied Microarrays Inc.
- Arrayit Corp.
- Astute Medical Inc.
- Avacta
- Ayoxxa Biosystems Gmbh
- Bio-Rad Laboratories Inc.
- Bio-Techne Inc.
- Biodesix Inc.
- Biognosys Ag
- Biomerieux
- Bioproximity
- Brucker
- Cambridge Protein Arrays Ltd.
- Caprion Biosciences Inc.
- Cdi Laboratories Inc.
- Creative Proteomics Inc.
- Crelux Gmbh
- Crystalgenomics
- Danaher Corp.
- Epicypher
- Evotec
- Fluidigm
- GD Biosciences
- GE Healthcare
- GL Sciences
- Glaxosmithkline Plc
- Healthtell
- Hybrigenics Sa
- Immunovia
- Imtakt Corp.
- Indi Molecular
- Integrated Diagnostics Inc.
- Labcyte Inc.
- Luminex Corp.
- Merck Kgaa
- Mosaiques Diagnostics And Therapeutics Ag
- MRM Proteomics
- Ms Bioworks Llc
- Mycartis
- Myriad Genetics Inc.
- Nantomics
- Newomics
- Nirmidas Biotech
- OPKO Health Inc.
- Perkinelmer
- Pfizer
- Phylogica
- Pressure Biosciences Inc.
- Prometic Life Science Inc.
- Protagen Ag
- Protea Biosciences Inc.
- Proteocyte Ai
- Proteogenix
- Proteome Sciences
- Proteomics International
- Proteovista
- Qiagen Nv
- Quansys Biosciences
- Quanterix
- Quest Diagnostics
- Raybiotec
- Repligen Corp.
- Retrogenix
- Samdi Tech Inc.
- Sera Prognostics
- Shimadzu Corp.
- Showa Danko Kk
- Sigma-Aldrich Corp.
- Siscapa Assay Technologies
- Somalogic Inc.
- Sphere Fluidics
- Spoton Clinical Diagnostics
- SQI Diagnostics
- Thermofisher Scientific Inc.
- Thorne Diagnostics
- Vermillion
- Waters Corp.
- Xencor
